BiotechTube
Home/HEPHAISTOS-Pharma/Pr. Charles Dumontet
PC

Pr. Charles Dumontet

Deputy Director, Co-Founder

HEPHAISTOS-Pharma

Therapeutic Areas

Oncology

HEPHAISTOS-Pharma Pipeline

DrugIndicationPhase
HEPHA-440Solid Tumors (e.g., Osteosarcoma)Preclinical
HEPHA-440 + aPD-1Solid tumors in combination with checkpoint inhibitorPreclinical

Leadership Team at HEPHAISTOS-Pharma

DM
Dr. Martine Caroff
Chief Scientific Officer, Co-Founder
FC
Frederic Caroff
Chief Executive Officer
DS
David Sourdive
Chairman of the Board
View full HEPHAISTOS-Pharma profile